Koźniewska E, Michalik R, Rafałowska J, Gadamski R, Walski M, Frontczak-Baniewicz M, Piotrowski P, Czernicki Z
Department of Neurosurgery, M. Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.
J Physiol Pharmacol. 2006 Nov;57 Suppl 11:145-60.
The main consequence of subarachnoid hemorrhage, for those who survive bleeding, is delayed, persistent vasospasm of intracranial conduit arteries which occurs between the third and seventh day after the insult and results in symptomatic brain ischemia in about 40% of cases. This vasospasm is considered to be a major cause of disability of post-SAH patients. Despite extensive experimental and clinical research, mechanisms of vasospasm are not fully understood. Dysfunction of the endothelium resulting in enhanced production of vasoconstrictors, phenotypic changes of the receptors in endothelium and smooth muscle cells, increased sensitivity of vascular smooth muscle cells to vasoconstrictors, release of spasmogens from lysed blood clot and inflammatory response of the vascular wall have been demonstrated and discussed as pathological mechanisms participating in the development of spasm. In recent years more attention is paid to the functional and structural changes in microcirculation and a concept of microvascular spasm is evolving. Our experimental studies in rat model of SAH strongly suggest that microcirculatory dysfunction and delayed vasospasm are related to the severity of acute, transient ischemia caused by critical decrease of perfusion pressure and active vasoconstriction immediately after the bleeding.
对于蛛网膜下腔出血幸存者而言,其主要后果是颅内传导动脉出现延迟性持续性血管痉挛,这种痉挛发生在出血后的第三天至第七天,约40%的病例会导致症状性脑缺血。这种血管痉挛被认为是蛛网膜下腔出血后患者致残的主要原因。尽管进行了广泛的实验和临床研究,但血管痉挛的机制仍未完全明确。已证实并讨论了导致血管收缩剂产生增加的内皮功能障碍、内皮细胞和平滑肌细胞中受体的表型变化、血管平滑肌细胞对血管收缩剂的敏感性增加、溶解的血凝块释放痉挛原以及血管壁的炎症反应等作为参与痉挛发展的病理机制。近年来,人们更加关注微循环的功能和结构变化,微血管痉挛的概念也在不断演变。我们在大鼠蛛网膜下腔出血模型中的实验研究强烈表明,微循环功能障碍和延迟性血管痉挛与出血后灌注压急剧下降和主动血管收缩导致的急性短暂性缺血的严重程度有关。